Strategically targeting MYC in cancer

@inproceedings{Posternak2016StrategicallyTM,
  title={Strategically targeting MYC in cancer},
  author={Valeriya Posternak and Michael D. Cole},
  booktitle={F1000Research},
  year={2016}
}
MYC is a major driver of cancer cell growth and mediates a transcriptional program spanning cell growth, the cell cycle, metabolism, and cell survival. Many efforts have been made to deliberately target MYC for cancer therapy. A variety of compounds have been generated to inhibit MYC function or stability, either directly or indirectly. The most direct inhibitors target the interaction between MYC and MAX, which is required for DNA binding. Unfortunately, these compounds do not have the desired… CONTINUE READING
Highly Cited
This paper has 488 citations. REVIEW CITATIONS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

489 Citations

0200400201620172018
Citations per Year
Semantic Scholar estimates that this publication has 489 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
Showing 1-10 of 65 references

DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein

  • GE Winter, DL Buckley, J Paulk
  • degradation. Science
  • 2015

Similar Papers

Loading similar papers…